Did You Know? The Straight Facts about the Metabolic Disease Epidemic in Asia

mildred Uncategorised Leave a Comment

Metabolic diseases are one of many healthcare threats faced by the region, and Johnson & Johnson Innovation is committed to working with local governments, industry experts and innovators to develop solutions for patients across the region. Singapore is one of the major innovation hotspots where Johnson & Johnson Innovation is heavily investing efforts to strengthen its entrepreneurial ecosystem, beginning with …


Johnson & Johnson Innovation Strengthens Innovation Hubs in Asia Pacific through Singapore QuickFire Challenge – Metabolic Disease Innovation

mildred Uncategorised Leave a Comment

Asia Pacific is a region changing at a sometimes dizzying pace. Already comprising 60% of the world’s population, it is growing by some 14 million people per year.  Urbanisation is happening at a pace the world has never seen before,  allowing the equally unprecedented growth of the middle class.  Add to the mix some of the world’s most aging populations, …

lab technician pipette liquid into test tubes

Download inVentiv Health’s whitepaper on Understanding the Continuum of Clinical Collaboration: Maximizing Partner Relationships and Unlocking Greater Value

mildred Uncategorised Leave a Comment

As biopharma companies evaluate strategies to advance their products to market, they are increasingly doing so with new options on partnership.  CRO or Vendor partners are invited to solve challenges of capacity, quality, expertise, and infrastructure – but not necessarily all at the same time.  Effective solutions are therefore about taking the BEST approach (Blended Efficient Sustainable Team) that may …


Sponsored Blogpost

mildred Uncategorised Leave a Comment

COMPANY INTRODUCTION Lumosa Therapeutics is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases with unmet medical needs. The company is actively engaged in scientific licensing and new drug development under the “RESEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced multi-functional team of translational research, CMC, preclinical, …

Carl Firth, CEO & Founder, ASLAN pharma, Singapore

Interviewing ASLAN, a leading Singapore biotech

Emily Event News Leave a Comment

If you have been keeping a lookout for promising biotech companies in Asia to invest in, then you have probably heard about ASLAN, a Singapore based biotech company founded in 2010.  Dr Carl Firth, the CEO and founder and his team has worked tirelessly to build innovative therapeutic products focusing on treating patients in Asia, as well as several rare …

Vitalik Buterin, Cofounder of Ethereum speaking at BioPharma Asia Convention 2017, Singapore

How blockchain is disrupting the healthcare industry

Emily Event News Leave a Comment

Blockchain has the potential to improve data transparency and reduce both friction and costs of current intermediaries. While its application is pretty well known in banking and finance industry, the usage of blockchain in healthcare and life sciences field is still new. To give you a better understanding on how this technology will disrupt the healthcare industry, we invited Vitalik …

NIH researchers working on tissue chips for better disease modelling

Tissue chips to enable successful drug development

Emily Event News Leave a Comment

With the high levels of uncertainty when working on live animals and human models, it is unsurprising that approximately 30 percent of promising medications fail in human clinical trials because of their pharmacovigilance properties. Thus, eliminating adverse effects at the earlier stage of drug development process will save costs and time for sponsor companies investing in the research, enabling researchers …


CellProthera on regenerative medicine & global cardiac research

Emily Event News Leave a Comment

Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. Working on regenerative medicines to treat cardio diseases, CellProthera’s team aim to build a leading company in the field of regenerative medicine and put together every necessary effort to make …